Publications

2018

  1. Wallach D. (2018) Cold Spring Harbor perspectives in biology. 10, 10, 028431.  Abstract
  2. Kang T., Jeong J., Yang S., Kovalenko A. & Wallach D. (2018) Cell Death Differ. 25, 6, p. 1107-1117  Abstract
  3. , Galluzzi L., Vitale I. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract
    [All authors]

2017

  1. Boege Y., Malehmir M., Healy M. E. et al. (2017) Cancer Cell. 32, 3, p. 342-+  Abstract
    [All authors]
  2. Yoon S., Kovalenko A., Bogdanov K. & Wallach D. (2017) Immunity. 47, 1, p. 51-+  Abstract

2016

  1. Wallach D. & Kovalenko A. (2016) Compendium of Inflammatory Diseases.  Abstract
  2. Wallach D., Kang T. B., Dillon C. P. & Green D. R. (2016) Science (New York, N.Y.). 352, 6281, p. aaf2154-aaf2154  Abstract
  3. Yoon S., Bogdanov K., Kovalenko A. & Wallach D. (2016) Cell Death and Differentiation. 23, 2, p. 253-260  Abstract
  4. Wallach D. (2016) Seminars in Cell & Developmental Biology. 50, p. 105-114  Abstract
  5. Roles of TNF and Other Members of the TNF Family in the Regulation of Innate Immunity
    Wallach D. & Kovalenko A. (2016) Encyclopedia of Immunobiology. 2, p. 454-465  Abstract

2014

  1. Wallach D. (2014) Seminars in Immunology. 26, 3, p. 181-182  Abstract
  2. Wallach D., Kang T. B., Yang S. & Kovalenko A. (2014) Cytokine & Growth Factor Reviews. 25, 2, p. 157-165  Abstract
  3. Wallach D. & Kovalenko A. (2014) eLife. 3, e02583.  Abstract
  4. Kang T., Yang S., Toth B., Kovalenko A. & Wallach D. (2014) REGULATED CELL DEATH, PT B: NECROPTOTIC, AUTOPHAGIC AND OTHER NON-APOPTOTIC MECHANISMS. p. 67-81 (Methods in Enzymology).  Abstract
  5. Wallach D., Kang T. B. & Kovalenko A. (2014) Nature Reviews Immunology. 14, 1, p. 51-59  Abstract
  6. Wallach D., Kang T., Rajput A. et al. (2014) NECROTIC CELL DEATH. p. 117-133 (Cell Death in Biology and Diseases).  Abstract
    [All authors]

2013

  1. Wallach D. (2013) Cytokine. 63, 3, p. 225-229  Abstract
  2. Wallach D. & Kovalenko A. (2013) Molecular Cell. 50, 1, p. 1-2  Abstract
  3. Wallach D. & Kovalenko A. (2013) Immunity. 38, 3, p. 402-403  Abstract
  4. Kang T. B., Yang S., Toth B., Kovalenko A. & Wallach D. (2013) Immunity. 38, 1, p. 27-40  Abstract

2012

  1. Dillon C. P., Oberst A., Weinlich R., Janke L. J., Kang T. B., Ben-Moshe T., Mak T. W., Wallach D. & Green D. R. (2012) Cell Reports. 1, 5, p. 401-407  Abstract

2011

  1. Wallach D., Kovalenko A. & Kang T. B. (2011) Trends in Immunology. 32, 11, p. 505-509  Abstract
  2. Wallach D. (2011) Cytokine. 54, 3, p. 233-234  Abstract
  3. Rajput A., Kovalenko A., Bogdanov K., Yang S., Kang T. B., Kim J., Du J. & Wallach D. (2011) Immunity. 34, 3, p. 340-351  Abstract
  4. Rajput A., Kang T. B., Bogdanov K., Kim J., Ben-Moshe T., Kovalenko A. & Wallach D. (2011) Advances In Tnf Family Research. 691, p. 253-260  Abstract
  5. The Biennial International TNF Conferences and Their Proceedings Preface
    Wallach D. (2011) Advances In Tnf Family Research. 691, p. V-VIII  Abstract

2010

  1. Wallach D., Rajput A., Kang T. B., Kim J., Bogdanov K., Yang S. & Kovalenko A. (2010) Cytokine. 52, 2-Jan, p. 74-74  Abstract
  2. Wallach D., Kang T. B., Rajput A., Kim J., Bogdanov K., Yang S. & Kovalenko A. (2010) Clearance Of Dying Cells In Healthy And Diseased Immune Systems. 1209, p. 17-22  Abstract

2009

  1. Kovalenko A., Rajput A., Kim J., Kang T. B., Bogdanov K., Dittrich-Breiholz O., Kracht M., Brenner O. & Wallach D. (2009) Cytokine. 48, 2-Jan, p. 23-23  Abstract
  2. Kovalenko A., Kim J., Kang T. B., Rajput A., Bogdanov K., Dittrich-Breiholz O., Kracht M., Brenner O. & Wallach D. (2009) Journal of Experimental Medicine. 206, 10, p. 2161-2177  Abstract
  3. Wallach D. & Kovalenko A. (2009) Cytokine & Growth Factor Reviews. 20, 4, p. 259-269  Abstract
  4. Scharner D., Roessig L., Carmona G. et al. (2009) Arteriosclerosis Thrombosis and Vascular Biology. 29, 4, p. 571-U268  Abstract
    [All authors]

2008

  1. Wallach D. & Kovalenko A. (2008) Nature Immunology. 9, 12, p. 1325-1327  Abstract
  2. Wallach D., Kang T. & Kovalenko A. (2008) Cell Death and Differentiation. 15, 10, p. 1533-1541  Abstract
  3. Krelin Y., Zhang L., Kang T., Appel E., Kovalenko A. & Wallach D. (2008) Cell Death and Differentiation. 15, 9, p. 1350-1355  Abstract
  4. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice
    Kang T. B., Oh G., Scandella E., Bolinger B., Ludewig B., Kovalenko A. & Wallach D. (2008) Journal of Immunology. 181, 4, p. 2522-2532  Abstract
  5. Ben Moshe M. T., Kang T. B., Kovalenko A., Barash H., Abramovitch R., Galun E. & Wallach D. (2008) Cytokine & Growth Factor Reviews. 19, 4-Mar, p. 209-217  Abstract

2007

  1. Hoevelmeyer N., Wunderlich F. T., Massoumi R. et al. (2007) Journal of Experimental Medicine. 204, 11, p. 2615-2627  Abstract
    [All authors]
  2. Kang T. B., Kovalenko A., Kim J., Oh G., Ben-Moshe T., Rajput A. & Wallach D. (2007) Cytokine. 39, 1, p. 19-20  Abstract
  3. Peter M. E., Budd R. C., Desbarats J. et al. (2007) Cell. 129, 3, p. 447-450  Abstract
    [All authors]
  4. Ben Moshe M. T., Barash H., Kang T. B. et al. (2007) Hepatology. 45, 4, p. 1014-1024  Abstract
    [All authors]

2006

  1. Gyrd-Hansen M., Farkas T., Fehrenbacher N. et al. (2006) Molecular and Cellular Biology. 26, 21, p. 7880-7891  Abstract
    [All authors]
  2. Citri A., Harari D., Shohat G. et al. (2006) Journal of Biological Chemistry. 281, 20, p. 14361-14369  Abstract
    [All authors]
  3. Wei S. H. -., Ming-Lum A., Liu Y., Wallach D., Ong C. J., Chung S. W., Moore K. W. & Mui A. L. -. (2006) Journal of Interferon and Cytokine Research. 26, 5, p. 281-290  Abstract
  4. Kovalenko A. & Wallach D. (2006) Molecular Cell. 22, 4, p. 433-436  Abstract
  5. Helfer B., Boswell B., Finlay D. et al. (2006) Cancer Research. 66, 8, p. 4273-4278  Abstract
    [All authors]
  6. NF-kappa B-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity
    Sanchez-Valdepenas C., Martin A., Ramakrishnan P., Wallach D. & Fresno M. (2006) Journal of Immunology. 176, 8, p. 4666-4674  Abstract

2005

  1. MORT1/FADD is involved in liver regeneration
    Schuchmann M., Rueckert F., Garcia-Lazaro J. F. et al. (2005) World Journal of Gastroenterology. 11, 46, p. 7248-7253  Abstract
    [All authors]
  2. Wallach D. (2005) Nature Chemical Biology. 1, 2, p. 68-69  Abstract

2004

  1. Ramakrishnan P., Wang W. & Wallach D. (2004) Immunity. 21, 4, p. 477-489  Abstract
  2. Caspase-8 serves both apoptotic and nonapoptotic roles
    Kang T., Ben Moshe T., Varfolomeev E. et al. (2004) Journal of Immunology. 173, 5, p. 2976-2984  Abstract
    [All authors]
  3. Xanthoulea S., Pasparakis M., Kousteni S., Brakebusch C., Wallach D., Bauer J., Lassmann H. & Kollias G. (2004) Journal of Experimental Medicine. 200, 3, p. 367-376  Abstract
  4. Greenberger S., Shaish A., Varda-Bloom N. et al. (2004) Journal of Clinical Investigation. 113, 7, p. 1017-1024  Abstract
    [All authors]

2003

  1. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D. & Courtois G. (2003) Nature. 424, 6950, p. 801-805  Abstract
  2. Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
  3. Schuchmann M., Rueckert F., Varfolomeev E., Wallach D., Lohse A. & Galle P. (2003) Journal of Hepatology. 38, p. 20-20  Abstract
  4. Schuchmann M., Varfolomeev E., Hermann F. et al. (2003) Hepatology. 37, 1, p. 129-135  Abstract
    [All authors]

2002

  1. Heussler V., Rottenberg S., Schwab R. et al. (2002) Science. 298, 5595, p. 1033-1036  Abstract
    [All authors]
  2. Wallach D. (2002) Nature Immunology. 3, 9, p. 802-803  Abstract

2000

  1. Eliaz R., Wallach D. & Kost J. (2000) Pharmaceutical Research. 17, 12, p. 1546-1550  Abstract
  2. Zhang S., Kovalenko A., Cantarella G. & Wallach D. (2000) Immunity. 12, 3, p. 301-311  Abstract

1999

  1. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways
    Holtmann H., Winzen R., Holland P. et al. (1999) Molecular and Cellular Biology. 19, 10, p. 6742-6753  Abstract
    [All authors]
  2. Hot papers - Signal transduction - MAP3K-related kinase involved in NF-kappa B induction by TNF, CD95 and IL-1 by N.L. Malinin, M.P. Boldin, A.V. Kovalenko, D. Wallach - Comments
    Wallach D. (1999) Scientist. 13, 17, p. 11-11  Abstract
  3. Watts A., Hunt N., Wanigasekara Y., Bloomfield G., Wallach D., Roufogalis B. & Chaudhri G. (1999) EMBO Journal. 18, 8, p. 2119-2126  Abstract
  4. Li Y., Kang J., Friedman J., Tarassishin L., Ye J., Kovalenko A., Wallach D. & Horwitz M. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 3, p. 1042-1047  Abstract
  5. Wallach D., Varfolomeev E., Malinin N., Goltsev Y., Kovalenko A. & Boldin M. (1999) Annual Review of Immunology. 17, p. 331-367  Abstract

1998

  1. Sylla B., Hung S., Davidson D., Hatzivassiliou E., Malinin N., Wallach D., Gilmore T., Kieff E. & Mosialos G. (1998) Proceedings of the National Academy of Sciences of the United States of America. 95, 17, p. 10106-10111  Abstract
  2. Varfolomeev E., Schuchmann M., Luria V. et al. (1998) Immunity. 9, 2, p. 267-276  Abstract
    [All authors]
  3. Wallach D., Kovalenko A., Varfolomeev E. & Boldin M. (1998) Current Opinion in Immunology. 10, 3, p. 279-288  Abstract
  4. Akiba H., Nakano H., Nishinaka S. et al. (1998) Journal of Biological Chemistry. 273, 21, p. 13353-13358  Abstract
    [All authors]
  5. Wallach D., Boldin M., Kovalenko A., Malinin N., Mett I. & Camonis J. (1998) Current Opinion in Immunology. 10, 2, p. 131-136  Abstract
  6. Carpentier I., Declercq W., Malinin N., Wallach D., Fiers W. & Beyaert R. (1998) FEBS Letters. 425, 2, p. 195-198  Abstract
  7. Aderka D., Sorkine P., Abu-Abid S., Lev D., Setton A., Cope A., Wallach D. & Klausner J. (1998) Journal of Clinical Investigation. 101, 3, p. 650-659  Abstract
  8. Hot papers - Biochemistry - Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-iduced cell death by M.P. Boldin, T.M. Goncharov, Y.V. Goltsev, D. Wallach - Comments
    Wallach D. (1998) Scientist. 12, 3, p. 13-13  Abstract

1997

  1. Goltsev Y., Kovalenko A., Arnold E., Varfolomeev E., Brodianskii V. & Wallach D. (1997) Journal of Biological Chemistry. 272, 32, p. 19641-19644  Abstract
  2. Wallach D. (1997) Nature. 388, 6638, p. 123-&  Abstract
  3. Wallach D., Boldin M., Varfolomeev E., Beyaert R., Vandenabeele P. & Fiers W. (1997) FEBS Letters. 410, 1, p. 96-106  Abstract
  4. Wallach D. (1997) Trends in Biochemical Sciences. 22, 4, p. 107-109  Abstract
  5. Malinin N., Boldin M., Kovalenko A. & Wallach D. (1997) Nature. 385, 6616, p. 540-544  Abstract

1996

  1. A decade of accumulated knowledge and emerging answers - The 6th international congress on TNF - Rhodes, Greece. May 1996
    Wallach D. (1996) European Cytokine Network. 7, 4, p. 713-724  Abstract
  2. Kupferminc M., Peaceman A., Aderka D., Wallach D. & Socol M. (1996) Obstetrics and Gynecology. 88, 3, p. 420-427  Abstract
  3. Eliaz R., Wallach D. & Kost J. (1996) Cytokine. 8, 6, p. 482-487  Abstract
  4. Boldin M., Goncharov T., Goltsev Y. & Wallach D. (1996) Cell. 85, 6, p. 803-815  Abstract
  5. Inhibition of tumor necrosis factor alpha (TNF alpha) activity in rat brain is associated with cerebroprotection after closed head injury
    Shohami E., Bass R., Wallach D., Yamin A. & Gallily R. (1996) Journal of Cerebral Blood Flow and Metabolism. 16, 3, p. 378-384  Abstract
  6. Turkaspa I., Maor Y., Weissenberg R., Madgar I., Aderka D., Dor J., Mashiach S. & Wallach D. (1996) Journal of Urology. 155, 4, p. 1436-1438  Abstract
  7. Varfolomeev E., Boldin M., Goncharov T. & Wallach D. (1996) Journal of Experimental Medicine. 183, 3, p. 1271-1275  Abstract

1995

  1. INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA RECEPTORS IN THE BRAINS OF PATIENTS WITH AIDS
    Sippy B., Hofman F., Wallach D. & Hinton D. (1995) Journal of Acquired Immune Deficiency Syndromes. 10, 5, p. 511-521  Abstract
  2. Feinstein E., Kimchi A., Wallach D., Boldin M. & Varfolomeev E. (1995) Trends in Biochemical Sciences. 20, 9, p. 342-344  Abstract
  3. Kupferminc M., Peaceman A., Aderka D., Wallach D., Peyser M., Lessing J. & Socol M. (1995) American Journal of Obstetrics and Gynecology. 173, 3, p. 900-905  Abstract
  4. Kalinkovich A., Geleziunas R., Kemper O., Belenki D., Wallach D., Wainberg M. & Bentwich Z. (1995) Journal of Interferon and Cytokine Research. 15, 9, p. 749-757  Abstract
  5. Schuchmann M., Hess S., Bufler P., Brakebusch C., Wallach D., Porter A., Riethmuller G. & Engelmann H. (1995) European Journal of Immunology. 25, 8, p. 2183-2189  Abstract
  6. Opsjon S., Novick D., Wathen N., Cope A., Wallach D. & Aderka D. (1995) Journal of Reproductive Immunology. 29, 2, p. 119-134  Abstract
  7. Porat R., Paddock H., Schwaitzberg S. et al. (1995) Critical Care Medicine. 23, 6, p. 1080-1089  Abstract
    [All authors]
  8. Boldin M., Mett I. & Wallach D. (1995) FEBS Letters. 367, 1, p. 39-44  Abstract
  9. A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN
    Boldin M., Varfolomeev E., Pancer Z., Mett I., Camonis J. & Wallach D. (1995) Journal of Biological Chemistry. 270, 14, p. 7795-7798  Abstract
  10. Tumor necrosis factor receptors of the monocyte derived Langerhans cell phenotype ''MoLC''
    Rossi G., Alijagic S., Schoeler D., Schmitt M., Graf H., Czarnetzki B. & Wallach D. (1995) Dendritic Cells In Fundamental And Clinical Immunology, Vol 2. 378, p. 129-133  Abstract
  11. SOLUBLE TNF RECEPTOR PRODUCTION BY ACTIVATED T-LYMPHOCYTES - DIFFERENTIAL-EFFECTS OF ACUTE AND CHRONIC EXPOSURE TO TNF
    Cope A., Aderka D., Wallach D., Kahan M., Chu N., Brennan F. & Feldmann M. (1995) Immunology. 84, 1, p. 21-30  Abstract
  12. SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    Boldin M., Mett I., Varfolomeev E., Chumakov I., Shemeravni Y., Camonis J. & Wallach D. (1995) Journal of Biological Chemistry. 270, 1, p. 387-391  Abstract
  13. PHOSPHORYLATION OF THE 26 KDA TNF PRECURSOR IN MONOCYTIC CELLS AND IN TRANSFECTED HELA-CELLS
    Pocsik E., Duda E. & Wallach D. (1995) Circulatory Shock. 45, 3, p. 152-160  Abstract

1994

  1. Kuhnert P., Kemper O. & Wallach D. (1994) Gene. 150, 2, p. 381-386  Abstract
  2. STRUCTURAL REQUIREMENTS FOR INDUCIBLE SHEDDING OF THE P55 TUMOR-NECROSIS-FACTOR RECEPTOR
    Brakebusch C., Varfolomeev E., Batkin M. & Wallach D. (1994) Journal of Biological Chemistry. 269, 51, p. 32488-32496  Abstract
  3. Bigda J., Beletsky I., Brakebusch C., Varfolomeev Y., Engelmann H., Holtmann H. & Wallach D. (1994) Journal of Experimental Medicine. 180, 2, p. 445-460  Abstract
  4. Boka G., Anglade P., Wallach D., Javoyagid F., Agid Y. & Hirsch E. (1994) Neuroscience Letters. 172, 2-Jan, p. 151-154  Abstract
  5. ELEVATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BIOLOGICAL-ACTIVITY IN PSORIATIC SKIN-LESIONS
    Ettehadi P., Greaves M., Wallach D., Aderka D. & Camp R. (1994) Clinical and Experimental Immunology. 96, 1, p. 146-151  Abstract
  6. TNF-ALPHA BINDS TO THE N-TERMINAL DOMAIN OF FIBRONECTIN AND AUGMENTS THE BETA(1)-INTEGRIN-MEDIATED ADHESION OF CD4+ T-LYMPHOCYTES TO THE GLYCOPROTEIN
    Alon R., Cahalon L., Hershkoviz R., Elbaz D., Reizis B., Wallach D., Akiyama S., Yamada K. & Lider O. (1994) Journal of Immunology. 152, 3, p. 1304-1313  Abstract
  7. VARIATIONS IN EFFECTIVITY OF MECHANISMS WHICH RESTRICT THE CELLULAR-RESPONSE TO TNF
    Wallach D., Bigda J., Brakebusch C. et al. (1994) Molecular Basis Of Inflammation. 3, p. 169-178  Abstract
    [All authors]

1993

  1. Kemper O. & Wallach D. (1993) Gene. 134, 2, p. 209-216  Abstract
  2. Molyneux M., Engelmann H., Taylor T., Wirima J., Aderka D., Wallach D. & Grau G. (1993) Cytokine. 5, 6, p. 604-609  Abstract
  3. Kalinkovich A., Livshits G., Engelmann H., Harpaz N., Burstein R., Kaminsky M., Wallach D. & Bentwich Z. (1993) Clinical and Experimental Immunology. 93, 3, p. 350-355  Abstract
  4. Ythier A., Gascon M., Juillard P., Vesin C., Wallach D. & Grau G. (1993) Cytokine. 5, 5, p. 459-462  Abstract
  5. Aderka D., Wysenbeek A., Engelmann H. et al. (1993) Arthritis and Rheumatology. 36, 8, p. 1111-1120  Abstract
    [All authors]
  6. Miltenburg A., Aderka D., Vanlaar J., Wallach D. & Breedveld F. (1993) Rheumatology International. 13, 3, p. 117-119  Abstract
  7. Cope A., Gibbons D., Aderka D., Foxwell B., Wallach D., Maini R., Feldmann M. & Brennan F. (1993) Cytokine. 5, 3, p. 205-212  Abstract
  8. SELECTIVE UP-REGULATION OF THE 75-KDA TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND ITS MESSENGER-RNA BY TNF AND IL-1
    Winzen R., Wallach D., Kemper O., Resch K. & Holtmann H. (1993) Journal of Immunology. 150, 10, p. 4346-4353  Abstract
  9. Belldegrun A., Pierce W., Sayah D., Dekernion J., Wallach D., Aderka D. & Figlin R. (1993) Journal of Immunotherapy. 13, 3, p. 175-180  Abstract
  10. INTERLEUKIN-6 INHIBITS THE PROLIFERATION OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS THAT IS INDUCED BY TUMOR-NECROSIS-FACTOR-ALPHA OR FACTOR-BETA
    Aderka D., Maor Y., Novick D., Engelmann H., Kahn Y., Levo Y., Wallach D. & Revel M. (1993) Blood. 81, 8, p. 2076-2084  Abstract
  11. EXTRACELLULAR-MATRIX INDUCES TUMOR-NECROSIS-FACTOR-ALPHA SECRETION BY AN INTERACTION BETWEEN RESTING RAT CD4+ T-CELLS AND MACROPHAGES
    Hershkoviz R., Gilat D., Miron S., Mekori Y., Aderka D., Wallach D., Vlodavsky I., Cohen I. R. & Lider O. (1993) Immunology. 78, 1, p. 50-57  Abstract

1992

  1. Miles D., Aderka D., Engelmann H., Wallach D. & Balkwill F. (1992) British Journal of Cancer. 66, 6, p. 1195-1199  Abstract
  2. Cope A., Aderka D., Doherty M. et al. (1992) Arthritis and Rheumatology. 35, 10, p. 1160-1169  Abstract
    [All authors]
  3. ELEVATED SERUM LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS (STNF-R) IN PATIENTS WITH HIV-INFECTION
    Kalinkovich A., Engelmann H., Harpaz N., Burstein R., Barak V., Kalickman I., Wallach D. & Bentwich Z. (1992) Clinical and Experimental Immunology. 89, 3, p. 351-355  Abstract
  4. PHARMACOKINETICS AND TISSUE DISTRIBUTION OF HUMAN URINARY TUMOR-NECROSIS-FACTOR BINDING-PROTEIN IN MICE
    Gascon M., Porchet H., Lecotonnec J., Ythier A., Wallach D., Piguet P. & Grau G. (1992) Drug Metabolism and Disposition. 20, 4, p. 592-595  Abstract
  5. SELECTIVE DECREASE IN CELL-SURFACE EXPRESSION AND MESSENGER-RNA LEVEL OF THE 55-KDA TUMOR-NECROSIS-FACTOR RECEPTOR DURING DIFFERENTIATION OF HL-60 CELLS INTO MACROPHAGE-LIKE BUT NOT GRANULOCYTE-LIKE CELLS
    Winzen R., Wallach D., Engelmann H., Nophar Y., Brakebusch C., Kemper O., Resch K. & Holtmann H. (1992) Journal of Immunology. 148, 11, p. 3454-3460  Abstract
  6. Variation in serum levels of the soluble TNF receptors among healthy individuals
    Aderka D., Engelmann H., Shemer-Avni Y., Hornik V., Galil A., Sarov B. & Wallach D. (1992) Lymphokine and Cytokine Research. 11, 3, p. 157-159  Abstract
  7. Brakebusch C., Nophar Y., Kemper O., Engelmann H. & Wallach D. (1992) EMBO Journal. 11, 3, p. 943-950  Abstract
  8. Aderka D., Engelmann H., Maor Y., Brakebusch C. & Wallach D. (1992) Journal of Experimental Medicine. 175, 2, p. 323-329  Abstract

1991

  1. HUMAN NEUTROPHIL ELASTASE RELEASES A LIGAND-BINDING FRAGMENT FROM THE 75-KDA TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR - COMPARISON WITH THE PROTEOLYTIC ACTIVITY RESPONSIBLE FOR SHEDDING OF TNF RECEPTORS FROM STIMULATED NEUTROPHILS
    Porteu F., Brockhaus M., Wallach D., Engelmann H. & Nathan C. (1991) Journal of Biological Chemistry. 266, 28, p. 18846-18853  Abstract
  2. INCREASED SERUM LEVELS OF SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CANCER-PATIENTS
    Aderka D., Engelmann H., Hornik V., Skornick Y., Levo Y., Wallach D. & Kushtai G. (1991) Cancer Research. 51, 20, p. 5602-5607  Abstract
  3. THE GENE FOR THE TYPE-II (P75) TUMOR-NECROSIS-FACTOR RECEPTOR (TNF-RII) IS LOCALIZED ON BAND 1P36.2-P36.3
    Kemper O., Derre J., Cherif D., Engelmann H., Wallach D. & Berger R. (1991) Human Genetics. 87, 5, p. 623-624  Abstract
  4. Konig M., Wallach D., Resch K. & Holtmann H. (1991) European Journal of Immunology. 21, 7, p. 1741-1745  Abstract
  5. Sarov I., Geron E., Shemeravni Y., Manor E., Zvillich M., Wallach D., Schmitz E. & Holtman H. (1991) European Journal Of Clinical Microbiology & Infectious Diseases. 10, 2, p. 119-123  Abstract
  6. Holtmann H., Brakebusch C., Konig M., Klocke R., Winzen R., Resch K. & Wallach D. (1991) Inflammation Research. 32, 2-Jan, p. 106-108  Abstract
  7. SOLUBLE AND CELL-SURFACE RECEPTORS FOR TUMOR-NECROSIS-FACTOR
    Wallach D., Engelmann H., Nophar Y., Aderka D., Kemper O., Hornik V., Holtmann H. & Brakebusch C. (1991) Progress Inflammation Research And Therapy. 35, p. 51-57  Abstract

1990

  1. INHIBITION OF GROWTH OF CHLAMYDIA-TRACHOMATIS BY TUMOR-NECROSIS-FACTOR IS ACCOMPANIED BY INCREASED PROSTAGLANDIN SYNTHESIS
    Holtmann H., Shemeravni Y., Wessel K., Sarov I. & Wallach D. (1990) Infection and Immunity. 58, 10, p. 3168-3172  Abstract
  2. Nophar Y., Kemper O., Brakebusch C., Engelmann H., Zwang R., Aderka D., Holtmann H. & Wallach D. (1990) EMBO Journal. 9, 10, p. 3269-3278  Abstract
  3. Engelmann H., Holtmann H., Brakebusch C., Avni Y., Sarov I., Nophar Y., Hadas E., Leitner O. & Wallach D. (1990) Journal of Biological Chemistry. 265, 24, p. 14497-14504  Abstract
  4. Novick D., Engelmann H., Wallach D., Leitner O., Revel M. & Rubinstein M. (1990) Journal of Chromatography. 510, p. 331-337  Abstract
  5. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors
    Engelmann H., Novick D. & Wallach D. (1990) Journal of Biological Chemistry. 265, 3, p. 1531-1536  Abstract
  6. MECHANISMS INVOLVED IN REGULATION OF THE RESPONSE TO TUMOR-NECROSIS-FACTOR - POSSIBLE ROLES FOR PROSTAGLANDIN PRODUCTION IN SENSITIZATION TO TNF EFFECTS AND FOR A SPECIFIC TNF-BINDING PROTEIN IN PROTECTION FROM THEM
    Wallach D., Aderka D., Rubinstein M., Engelmann H., Avni Y., Sarov I. & Holtmann H. (1990) Tumor Necrosis Factor : Structure, Mechanism Of Action, Role In Disease And Therapy. p. 146-155  Abstract
  7. SOLUBLE CYTOKINE-RECEPTORS ARE PRESENT IN NORMAL HUMAN URINE
    Novick D., Engelmann H., Wallach D. & Rubinstein M. (1990) Physiological And Pathological Effects Of Cytokines. 10, p. 413-421  Abstract
  8. SOLUBLE FORMS OF THE TNF RECEPTORS, PURIFIED FROM HUMAN URINE, INHIBIT TNF EFFECTS - ANTIBODIES AGAINST THE SOLUBLE RECEPTORS INDUCE TNF-LIKE EFFECTS
    Engelmann H., Aderka D., Holtmann H. et al. (1990) Molecular And Cellular Biology Of Cytokines. 10, p. 299-308  Abstract
    [All authors]

1989

  1. Israel A., Le Bail O., Hatat D., Piette J., Kieran M., Logeat F., Wallach D., Fellous M. & Kourilsky P. (1989) EMBO Journal. 8, 12, p. 3793-3800  Abstract
  2. REVERSION OF THE ANTICHLAMYDIAL EFFECT OF TUMOR NECROSIS FACTOR BY TRYPTOPHAN AND ANTIBODIES TO BETA-INTERFERON
    Shemeravni Y., Wallach D. & Sarov I. (1989) Infection and Immunity. 57, 11, p. 3484-3490  Abstract
  3. Novick D., Engelmann H., Wallach D. & Rubinstein M. (1989) Journal of Experimental Medicine. 170, 4, p. 1409-1414  Abstract
  4. A TUMOR NECROSIS FACTOR-BINDING PROTEIN PURIFIED TO HOMOGENEITY FROM HUMAN-URINE PROTECTS CELLS FROM TUMOR NECROSIS FACTOR TOXICITY
    Engelmann H., Aderka D., Rubinstein M., Rotman D. & Wallach D. (1989) Journal of Biological Chemistry. 264, 20, p. 11974-11980  Abstract
  5. MECHANISMS WHICH TAKE PART IN REGULATION OF THE RESPONSE TO TUMOR NECROSIS FACTOR
    Wallach D., Holtmann H., Aderka D., Rubinstein M., Avni Y., Sarov I. & Engelman H. (1989) Lymphokine Research. 8, 3, p. 359-363  Abstract

1988

  1. Ophir D., Hahn T., Schattner A., Wallach D. & Aviel A. (1988) Archives Of Otolaryngology-Head & Neck Surgery. 114, 11, p. 1256-1258  Abstract
  2. INHIBITION OF CHLAMYDIA-TRACHOMATIS GROWTH BY RECOMBINANT TUMOR NECROSIS FACTOR
    Shemeravni Y., Wallach D. & Sarov I. (1988) Infection and Immunity. 56, 9, p. 2503-2506  Abstract
  3. Schattner A., Wallach D. & Revel M. (1988) American Journal of Medicine. 85, 3, p. 457-458  Abstract
  4. Aderka D., Michalevicz R., Daniel Y. et al. (1988) Cancer. 61, 11, p. 2207-2213  Abstract
    [All authors]
  5. Wallach D., Holtmann H., Aderka D., Hahn T., Engelmann H. & Nophar Y. (1988) Annales De L Institut Pasteur-Immunology. 139, 3, p. 323-327  Abstract
  6. SENSITIZATION AND DESENSITIZATION TO LETHAL EFFECTS OF TUMOR NECROSIS FACTOR AND IL-1
    Wallach D., Holtmann H., Engelmann H. & Nophar Y. (1988) Journal of Immunology. 140, 9, p. 2994-2999  Abstract
  7. DOMINANCE OF RESISTANCE TO THE CYTOCIDAL EFFECT OF TUMOR NECROSIS FACTOR IN HETEROKARYONS FORMED BY FUSION OF RESISTANT AND SENSITIVE CELLS
    Nophar Y., Holtmann H., Ber R. & Wallach D. (1988) Journal of Immunology. 140, 10, p. 3456-3460  Abstract
  8. INTERRELATED EFFECTS OF TUMOR NECROSIS FACTOR AND INTERLEUKIN 1 ON CELL VIABILITY
    Holtmann H., Hahn T. & Wallach D. (1988) Immunobiology. 177, 1, p. 7-22  Abstract
  9. CLONING OF GENOMIC DNA FOR TUMOR NECROSIS FACTOR AND EFFICIENT EXPRESSION IN CHO CELLS
    Korn J., Mory Y., Ziberstein A., Holtmann H., Revel M. & Wallach D. (1988) Lymphokine Research. 7, 4, p. 349-358  Abstract

1987

  1. Aderka D., Levo Y., Ramot B. et al. (1987) Cancer. 60, 9, p. 2208-2212  Abstract
    [All authors]
  2. DOWN REGULATION OF THE RECEPTORS FOR TUMOR-NECROSIS-FACTOR BY INTERLEUKIN-1 AND 4-BETA-PHORBOL-12-MYRISTATE-13-ACETATE
    Holtmann H. & Wallach D. (1987) Journal of Immunology. 139, 4, p. 1161-1167  Abstract
  3. Eife R., Mullerwiefel D., Sigmund B., Mehls O., Engelmann H. & Wallach D. (1987) Pediatric Research. 22, 2, p. 224-224  Abstract
  4. HEMORRHAGIC NECROSIS AND COAGULATION NECROSIS
    Bloksma N., Wallach D., Pober J., Old L., Spriggs D., Cerami A., Schreiber H., Regenass U. & Nussenzweig V. (1987) Ciba Foundation Symposia. 131, p. 187-191  Abstract
  5. PROTECTIVE AND CYTOLYTIC EFFECTS OF TNF
    Wallach D., Cerami A., Granger G., Matthews N., Goldberg A., Baglioni C., Pober J. & Old L. (1987) Ciba Foundation Symposia. 131, p. 84-87  Abstract

1986

  1. Aderka D., Holtmann H., Toker L., Hahn T. & Wallach D. (1986) Journal of Immunology. 136, 8, p. 2938-2942  Abstract
  2. Israel S., Hahn T., Holtmann H. & Wallach D. (1986) Immunology Letters. 12, 4, p. 217-224  Abstract

1985

  1. RAPID IMPROVEMENT IN A TERMINAL CASE OF HAIRY-CELL LEUKEMIA TREATED WITH A NEW HUMAN RECOMBINANT INTERFERON, IFN-ALPHA-C
    Aderka D., Levo Y., Rahmani R. et al. (1985) Israel Medical Association Journal. 21, 12, p. 977-981  Abstract
    [All authors]
  2. Aderka D., Novick D., Hahn T., Fischer D. & Wallach D. (1985) Cellular Immunology. 92, 2, p. 218-225  Abstract
  3. Schoenfeld A., Ovadia J., Levavi C., Nitke S., Wallach D., Schattner A. & Revel M. (1985) Early Human Development. 10, 4-Mar, p. 279-286  Abstract
  4. Hahn T., Toker L., Budilovsky S., Aderka D., Eshhar Z. & Wallach D. (1985) Proceedings of the National Academy of Sciences of the United States of America. 82, 11, p. 3814-3818  Abstract
  5. CACHECTIN TUMOR-NECROSIS-FACTOR PRODUCTION BY CANCER-PATIENTS
    Aderka D., Fisher S., Levo Y., Holtmann H., Hahn T. & Wallach D. (1985) Lancet. 2, 8465, p. 1190-1190  Abstract
  6. INVOLVEMENT OF CYTOTOXINS IN THE IMMUNE-RESPONSE TO VIRAL-INFECTION
    Aderka D., Hahn T. & Wallach D. (1985) Antiviral Research. p. 141-148  Abstract

1984

  1. Schattner A., Merlin G., Bregman V., Hahn T., Levin S., Revel M. & Wallach D. (1984) Clinical and Experimental Immunology. 57, 2, p. 265-270  Abstract
  2. INTRAMUSCULAR HUMAN INTERFERON-BETA INJECTIONS IN TREATMENT OF CONDYLOMATA ACUMINATA
    Schonfeld A., Schattner A., Crespi M. et al. (1984) Lancet. 1, 8385, p. 1038-1042  Abstract
    [All authors]
  3. Wallach D., Hahn T. & Budilovsky S. (1984) FEBS Letters. 178, 2, p. 257-263  Abstract
  4. PREPARATIONS OF LYMPHOTOXIN INDUCE RESISTANCE TO THEIR OWN CYTO-TOXIC EFFECT
    Wallach D. (1984) Journal of Immunology. 132, 5, p. 2464-2469  Abstract
  5. Shoham J., Cohen M. & Wallach D. (1984) Journal of Immunological Methods. 72, 1, p. 279-287  Abstract

1983

  1. Rosa F., Hatat D., Abadie A., Wallach D., Revel M. & Fellous M. (1983) EMBO Journal. 2, 9, p. 1585-1589  Abstract
  2. Wallach D. & Hahn T. (1983) Cellular Immunology. 76, 2, p. 390-396  Abstract
  3. Schattner A., Meshorer A. & Wallach D. (1983) Cellular Immunology. 79, 1, p. 11-25  Abstract

1982

  1. INTERFERON-INDUCED PROTEINS - BIOLOGICAL FUNCTIONS AND CLINICAL-APPLICATIONS
    Wallach D., Schattner A., Merlin G., Kimchi A., Fellous M. & Revel M. (1982) Ucla Symposia On Molecular And Cellular Biology. 25, p. 449-463  Abstract
  2. Schattner A., Wallach D., Merlin G., Hahn T., Levin S., Ramot B. & Revel M. (1982) Journal of Interferon Research. 2, 3, p. 355-361  Abstract
  3. Schattner A., Merlin G., Shapira A., Revel M. & Wallach D. (1982) Journal of Interferon Research. 2, 2, p. 285-289  Abstract
  4. Zor U., Bendori R., Maoz I., Wallach D. & Gurarirotman D. (1982) Journal of General Virology. 63, DEC, p. 359-363  Abstract
  5. Fellous M., Nir U., Wallach D., Merlin G., Rubinstein M. & Revel M. (1982) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79, 10, p. 3082-3086  Abstract
  6. INTERFERON AS A POSSIBLE CAUSE FOR VIRUS-RELATED LYMPHOCYTOPENIA
    Schattner A., Meshorer A., Revel M. & Wallach D. (1982) Israel Medical Association Journal. 18, 9, p. 965-966  Abstract

1981

  1. Merlin G., Revel M. & Wallach D. (1981) Analytical Biochemistry. 110, 1, p. 190-196  Abstract
  2. ASSAY OF AN INTERFERON-INDUCED ENZYME IN WHITE BLOOD-CELLS AS A DIAGNOSTIC-AID IN VIRAL DISEASES
    Schattner A., Merlin G., Levin S., Wallach D., Hahn T. & Revel M. (1981) Lancet. 2, 8245, p. 497-500  Abstract
  3. Schattner A., Merlin G., Wallach D., Rosenberg H., Bino T., Hahn T., Levin S. & Revel M. (1981) Journal of Interferon Research. 1, 4, p. 587-594  Abstract

1980

  1. Wallach D. & Revel M. (1980) Nature. 287, 5777, p. 68-70  Abstract
  2. Weissenbach J., Chernajovsky Y., Zeevi M. et al. (1980) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 77, 12, p. 7152-7156  Abstract
    [All authors]

1979